Please enable JavaScript to continue using this application.

Compare $OCGN vs $ZNTL | Chartloom

Compare

$OCGN vs $ZNTL

Ocugen Inc · Zentalis Pharmaceuticals Inc

OCGN

Ocugen Inc

ZNTL

Zentalis Pharmaceuticals Inc

Compare $OCGN vs $ZNTL

Comparing Ocugen Inc and Zentalis Pharmaceuticals Inc

OCGNOcugen Inc

ZNTLZentalis Pharmaceuticals Inc

OCGNOcugen Inc

Market cap

$323M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

181.62x

Rev growth (TTM)

0.4%

YTD performance

-30.8%

52W performance

-46.6%

FCF yield

-18.9%

ZNTLZentalis Pharmaceuticals Inc

Market cap

$188M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

92.7%

52W performance

61.0%

FCF yield

-68.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

OCGN

ZNTL

Detailed metrics comparison

OCGN

Ocugen Inc

ZNTL

Zentalis Pharmaceuticals Inc

Market Cap

OCGN$323M

ZNTL$188M

Enterprise Value

OCGN$308M

ZNTL$163M

Price

OCGN$0.96

ZNTL$2.64

P/E Ratio

OCGNN/A

ZNTLN/A

P/S Ratio

OCGN67.77x

ZNTL0.00x

EV/Sales

OCGN64.43x

ZNTL0.00x

EV/EBITDA

OCGN0.00x

ZNTL0.00x

P/B Ratio

OCGN59.59x

ZNTL1.70x

P/FCF Ratio

OCGNN/A

ZNTLN/A

EV/FCF

OCGN-5.04x

ZNTL-1.27x

PEG Ratio

OCGNN/A

ZNTLN/A

Forward P/E (NTM)

OCGNN/A

ZNTLN/A

Forward P/S (NTM)

OCGN181.62x

ZNTLN/A

Revenue (TTM)

OCGN$5M

ZNTL$0

Revenue Growth (YoY)

OCGN0.4%

ZNTLN/A

Forward Rev Growth

OCGN-47.4%

ZNTL447.5%

Gross Margin (TTM)

OCGN0.0%

ZNTL0.0%

Operating Margin (TTM)

OCGN0.0%

ZNTL0.0%

EBITDA Margin (TTM)

OCGN-1043.0%

ZNTL0.0%

Net Margin (TTM)

OCGN-1343.1%

ZNTL0.0%

FCF Margin (TTM)

OCGN-1278.5%

ZNTLN/A

Net Income (TTM)

OCGN$-64M

ZNTL$-62M

FCF (TTM)

OCGN$-61M

ZNTL$-128M

EPS (TTM)

OCGN-$0.19

ZNTL$0.00

ROE (TTM)

OCGN-130671.0%

ZNTL-5277.0%

ROA (TTM)

OCGN-8057.0%

ZNTL-4055.0%

ROIC (TTM)

OCGN-16519.0%

ZNTL-5277.0%

Cash

OCGN$100M

ZNTL$25M

Debt

OCGN$84M

ZNTL$0

Net Cash/Debt

OCGN$16M

ZNTL$25M

Current Ratio (TTM)

OCGN0.80x

ZNTL4.82x

Quick Ratio (TTM)

OCGN0.75x

ZNTL4.64x

Debt/Equity (TTM)

OCGN5.03x

ZNTL0.00x

Debt/Assets (TTM)

OCGN0.0%

ZNTL0.0%

Interest Coverage (TTM)

OCGNN/A

ZNTLN/A

Net Debt/EBITDA (TTM)

OCGN0.00x

ZNTL0.00x

Beta

OCGN1.91

ZNTL1.92

52W Performance

OCGN-46.6%

ZNTL61.0%

YTD Performance

OCGN-30.8%

ZNTL92.7%

% from 52W High

OCGN-64.9%

ZNTL-62.0%

% from 52W Low

OCGN6.2%

ZNTL117.8%

Asset Turnover (TTM)

OCGN0.06x

ZNTL0.00x

FCF Yield (TTM)

OCGN-18.9%

ZNTL-68.2%

Earnings Yield (TTM)

OCGN-19.8%

ZNTL-32.9%

Dividend Yield (TTM)

OCGNN/A

ZNTLN/A

Rule of 40

OCGN-1,278.1

ZNTL0.0

EV/GP/RG

OCGNN/A

ZNTLN/A

Ticker research

View OCGN research View ZNTL research

Metric	OCGN Ocugen Inc	ZNTL Zentalis Pharmaceuticals Inc
Market & Valuation
Market Cap	$323M	$188M
Enterprise Value	$308M	$163M
Price	$0.96	$2.64
P/E Ratio	N/A	N/A
P/S Ratio	67.77x	0.00x
EV/Sales	64.43x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	59.59x	1.70x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.04x	-1.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	181.62x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	0.4%	N/A
Forward Rev Growth	-47.4%	447.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1043.0%	0.0%
Net Margin (TTM)	-1343.1%	0.0%
FCF Margin (TTM)	-1278.5%	N/A
Net Income (TTM)	$-64M	$-62M
FCF (TTM)	$-61M	$-128M
EPS (TTM)	-$0.19	$0.00
ROE (TTM)	-130671.0%	-5277.0%
ROA (TTM)	-8057.0%	-4055.0%
ROIC (TTM)	-16519.0%	-5277.0%
Financial Health
Cash	$100M	$25M
Debt	$84M	$0
Net Cash/Debt	$16M	$25M
Current Ratio (TTM)	0.80x	4.82x
Quick Ratio (TTM)	0.75x	4.64x
Debt/Equity (TTM)	5.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.91	1.92
52W Performance	-46.6%	61.0%
YTD Performance	-30.8%	92.7%
% from 52W High	-64.9%	-62.0%
% from 52W Low	6.2%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.00x
FCF Yield (TTM)	-18.9%	-68.2%
Earnings Yield (TTM)	-19.8%	-32.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,278.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OCGN research	View ZNTL research

Valuation

P/S Ratio

ZNTL

0.00x

OCGN

67.77x

EV/FCF

OCGN

-5.04x

ZNTL

-1.27x

Growth & revenue

Revenue Growth TTM

OCGN

0.4%

Forward Revenue Growth

ZNTL

447.5%

OCGN

-47.4%

Profitability & performance

Gross Margin

OCGN

0.0%

ZNTL

0.0%

ROE

ZNTL

-5277.0%

OCGN

-130671.0%

FCF Yield %

OCGN

-18.9%

ZNTL

-68.2%

52-Week Performance

ZNTL

61.0%

OCGN

-46.6%

Detailed metrics comparison

OCGN

Ocugen Inc

ZNTL

Zentalis Pharmaceuticals Inc

Market Cap

OCGN$323M

ZNTL$188M

Enterprise Value

OCGN$308M

ZNTL$163M

Price

OCGN$0.96

ZNTL$2.64

P/E Ratio

OCGNN/A

ZNTLN/A

P/S Ratio

OCGN67.77x

ZNTL0.00x

EV/Sales

OCGN64.43x

ZNTL0.00x

EV/EBITDA

OCGN0.00x

ZNTL0.00x

P/B Ratio

OCGN59.59x

ZNTL1.70x

P/FCF Ratio

OCGNN/A

ZNTLN/A

EV/FCF

OCGN-5.04x

ZNTL-1.27x

PEG Ratio

OCGNN/A

ZNTLN/A

Forward P/E (NTM)

OCGNN/A

ZNTLN/A

Forward P/S (NTM)

OCGN181.62x

ZNTLN/A

Revenue (TTM)

OCGN$5M

ZNTL$0

Revenue Growth (YoY)

OCGN0.4%

ZNTLN/A

Forward Rev Growth

OCGN-47.4%

ZNTL447.5%

Gross Margin (TTM)

OCGN0.0%

ZNTL0.0%

Operating Margin (TTM)

OCGN0.0%

ZNTL0.0%

EBITDA Margin (TTM)

OCGN-1043.0%

ZNTL0.0%

Net Margin (TTM)

OCGN-1343.1%

ZNTL0.0%

FCF Margin (TTM)

OCGN-1278.5%

ZNTLN/A

Net Income (TTM)

OCGN$-64M

ZNTL$-62M

FCF (TTM)

OCGN$-61M

ZNTL$-128M

EPS (TTM)

OCGN-$0.19

ZNTL$0.00

ROE (TTM)

OCGN-130671.0%

ZNTL-5277.0%

ROA (TTM)

OCGN-8057.0%

ZNTL-4055.0%

ROIC (TTM)

OCGN-16519.0%

ZNTL-5277.0%

Cash

OCGN$100M

ZNTL$25M

Debt

OCGN$84M

ZNTL$0

Net Cash/Debt

OCGN$16M

ZNTL$25M

Current Ratio (TTM)

OCGN0.80x

ZNTL4.82x

Quick Ratio (TTM)

OCGN0.75x

ZNTL4.64x

Debt/Equity (TTM)

OCGN5.03x

ZNTL0.00x

Debt/Assets (TTM)

OCGN0.0%

ZNTL0.0%

Interest Coverage (TTM)

OCGNN/A

ZNTLN/A

Net Debt/EBITDA (TTM)

OCGN0.00x

ZNTL0.00x

Beta

OCGN1.91

ZNTL1.92

52W Performance

OCGN-46.6%

ZNTL61.0%

YTD Performance

OCGN-30.8%

ZNTL92.7%

% from 52W High

OCGN-64.9%

ZNTL-62.0%

% from 52W Low

OCGN6.2%

ZNTL117.8%

Asset Turnover (TTM)

OCGN0.06x

ZNTL0.00x

FCF Yield (TTM)

OCGN-18.9%

ZNTL-68.2%

Earnings Yield (TTM)

OCGN-19.8%

ZNTL-32.9%

Dividend Yield (TTM)

OCGNN/A

ZNTLN/A

Rule of 40

OCGN-1,278.1

ZNTL0.0

EV/GP/RG

OCGNN/A

ZNTLN/A

Ticker research

View OCGN research View ZNTL research

Metric	OCGN Ocugen Inc	ZNTL Zentalis Pharmaceuticals Inc
Market & Valuation
Market Cap	$323M	$188M
Enterprise Value	$308M	$163M
Price	$0.96	$2.64
P/E Ratio	N/A	N/A
P/S Ratio	67.77x	0.00x
EV/Sales	64.43x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	59.59x	1.70x
P/FCF Ratio	N/A	N/A
EV/FCF	-5.04x	-1.27x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	181.62x	N/A
Revenue & Growth
Revenue (TTM)	$5M	$0
Revenue Growth (YoY)	0.4%	N/A
Forward Rev Growth	-47.4%	447.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1043.0%	0.0%
Net Margin (TTM)	-1343.1%	0.0%
FCF Margin (TTM)	-1278.5%	N/A
Net Income (TTM)	$-64M	$-62M
FCF (TTM)	$-61M	$-128M
EPS (TTM)	-$0.19	$0.00
ROE (TTM)	-130671.0%	-5277.0%
ROA (TTM)	-8057.0%	-4055.0%
ROIC (TTM)	-16519.0%	-5277.0%
Financial Health
Cash	$100M	$25M
Debt	$84M	$0
Net Cash/Debt	$16M	$25M
Current Ratio (TTM)	0.80x	4.82x
Quick Ratio (TTM)	0.75x	4.64x
Debt/Equity (TTM)	5.03x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.91	1.92
52W Performance	-46.6%	61.0%
YTD Performance	-30.8%	92.7%
% from 52W High	-64.9%	-62.0%
% from 52W Low	6.2%	117.8%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.00x
FCF Yield (TTM)	-18.9%	-68.2%
Earnings Yield (TTM)	-19.8%	-32.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,278.1	0.0
EV/GP/RG	N/A	N/A
Ticker research	View OCGN research	View ZNTL research